83% HCPs say pharma providing more valuable information than pre-pandemic; study

9 December 2021

Pharmaceutical companies have increased their relevance during COVID-19 through more valuable and meaningful interactions with healthcare providers (HCPs), according to a new report from Accenture (NYSE: ACN).

The report, The "New" Rules of Engagement: How pharmaceutical companies can give HCPs the new and meaningful interactions they want, is based on a survey of 720 general practitioners, oncologists, cardiologists and immunologists globally. It found that 83% of providers believe the content received from pharma companies resonates more now than before the COVID-19 crisis, and 59% of providers said that data-driven recommendations – such as clinical trial data – are most helpful in shaping their treatment decisions.

Key findings include:

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK